Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Outcomes and prognosis news

Show

From To
Higher pill burden is associated with poorer adherence to HIV therapy and reduced chances of achieving an undetectable viral load

Lower pill burden is associated with higher rates of adherence to HIV treatment and better virological outcomes, according to the results of a meta-analysis published in the online

Published
31 January 2014
By
Michael Carter
Life expectancy now considerably exceeds the average in some people with HIV in the US

A study from the US has found that some groups of people with HIV, especially those treated before their CD4 count falls below 350 cells/mm3, now have life

Published
06 January 2014
By
Gus Cairns
Short course of ART during primary HIV infection has immunological and virological benefits after treatment is stopped

A short course of antiretroviral therapy during primary HIV infection (PHI) has immunological and virological benefits after treatment is stopped, a meta-analysis published in the online journal PLoS

Published
27 December 2013
By
Michael Carter
Botswana's ART programme achieves good results

Botswana’s antiretroviral treatment (ART) programme has achieved good results, analysis of nine years of data published in The Lancet Global Health shows. The overall mortality rate was 8%.

Published
20 December 2013
By
Michael Carter
Advances in HIV treatment dramatically increase life expectancy

An individual in North America beginning HIV treatment can now expect to live into their early 70s, a dramatic increase from just over 10 years ago, according to a new study from a collaboration of researchers led by the BC Centre for Excellence in HIV/AIDS (BC-CfE).

Published
19 December 2013
From
British Columbia Centre for Excellence in HIV/AIDS
HIV treatment in South Africa has had "astounding" benefits

The roll-out of antiretroviral therapy (ART) in South Africa has achieved “astounding” results, a mathematical model published in the online edition of the Journal of Infectious Diseases

Published
12 December 2013
By
Michael Carter
Severity of HIV seroconversion illness associated with subsequent disease progression

Severity of symptoms during primary HIV infection (PHI) is associated with subsequent disease progression, results of a study published in PLoS One show. People who had severe

Published
05 December 2013
By
Michael Carter
For women, HIV treatment based on atazanavir/ritonavir involves twice the risk of failure compared to efavirenz-containing therapy

Treatment outcomes differ between women taking first-line antiretroviral therapy based on ritonavir-boosted atazanavir and efavirenz, investigators from the United States report in the online edition of Clinical Infectious Diseases.

Published
04 December 2013
By
Michael Carter
Micronutrient supplements delay HIV disease progression for patients with higher CD4 cell counts

Long-term micronutrient supplementation delays HIV disease progression in people with higher CD4 cell counts, results of a study published in the Journal of the American Medical Association shows.

Published
28 November 2013
By
Michael Carter
How much longer have I got?

We’re concentrating on the future as a theme in this, the last-ever HIV treatment update. So it seems appropriate to have an update on exactly how much

Published
25 November 2013
From
HIV treatment update

Filter by country